Get started
Author

Pedro Pérez

Observed names: P.L. Perez, P.L. Pérez, Pedro L Perez, Pedro L. Perez, Pedro Perez
ORCID: 0009-0005-6629-6398
Observed ORCID: 0009-0005-6629-6398
OpenAlex ID: A5111762822
Results of the performance verification of the CoaguChek XS system
2008 · W. Plesch, T. Wolf, et al. · Thrombosis Research · 77
Automated Neutrophil Morphology and Its Utility in the Assessment of Neutrophil Dysplasia
2007 · Amparo Miguel, Maite Orero, et al. · Laboratory Hematology · 38
Effects of three feedback conditions on aerobic swim speeds.
2009 · Pedro Pérez, Salvador Llana, et al. · PubMed · 29
Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.
2017 · Sebastián Ortiz, Maria T Orero, et al. · PubMed · 11
Infection Rate and Risk Factors in Patients Treated With Azacitidine
2015 · M. Orero, C. Villegas, et al. · Clinical Lymphoma Myeloma & Leukemia · 7
Analysis of Rabbit Vascular Responses to DBI, an Ingol Derivative Isolated from Euphorbia canariensis
1997 · Francisco J Miranda, José A Alabadí, et al. · Journal of Pharmacy and Pharmacology · 4
Automated Neutrophil Morphology and Its Utility in the Assessment of Neutrophil Dysplasia and in the Diagnosis of Myelodysplastic Syndromes.
2006 · Amparo Miguel, Maite Orero, et al. · Blood · 3
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia
2024 · Catia Simoes, Carmen Gonzalez, et al. · Blood Neoplasia · 2
Ring of fire cells: plasma cell–predominant relapse of Waldenström macroglobulinemia
2026 · Pedro Perez, Alex Freire Sandes · Blood
PDF
Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“
2025 · Gabriel Cunha, Pedro Perez, et al. · Blood
PDF
P-232 Antioxidant system aberrations as response to generation of reactive oxygen species (ROS) in low/intermediate-1 risk myelodisplastic syndrome
2013 · D. Ivars Santacreu, R. Collado, et al. · Leukemia Research
Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload
2012 · David Ivars, Rosa Collado, et al. · Blood
Works count: 13
Citation count: 171
H-index: 5
I10-index: 4
Year
Topic
Type